Autosomal dominant spastic paraplegia type 3 (Q100878): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Paraplegia espástica autossômica dominante causada por defeito na proteína de ligação ao guanilato (ATL1) e se apresenta com início na infância de espasticidade minimamente progressiva, bilateral, principalmente simétrica dos membros inferiores e fraqueza associada a pés cavos, sensação de vibração diminuída, distúrbios do esfíncter e/ou bexiga urinária hiperativa. Manifestações adicionais associadas podem incluir escoliose, incapacidade intelectual leve, atrofia óptica, neuropatia motora axonal e/ou amiotrofia distal.
description / endescription / en
 
Autosomal dominant spastic paraplegia caused by defect of guanylate-binding protein (ATL1) and presents with childhood-onset of minimally progressive, bilateral, mainly symmetric lower limb spasticity and weakness associated with pes cavus, diminished vibration sense, sphincter disturbances and/or urinary bladder hyperactivity. Additional associated manifestations may include scoliosis, mild intellectual disability, optic atrophy, axonal motor neuropathy and/or distal amyotrophy.

Revision as of 17:39, 16 August 2026

Autosomal dominant spastic paraplegia caused by defect of guanylate-binding protein (ATL1) and presents with childhood-onset of minimally progressive, bilateral, mainly symmetric lower limb spasticity and weakness associated with pes cavus, diminished vibration sense, sphincter disturbances and/or urinary bladder hyperactivity. Additional associated manifestations may include scoliosis, mild intellectual disability, optic atrophy, axonal motor neuropathy and/or distal amyotrophy.
Language Label Description Also known as
default for all languages
ID_39845134
    English
    Autosomal dominant spastic paraplegia type 3
    Autosomal dominant spastic paraplegia caused by defect of guanylate-binding protein (ATL1) and presents with childhood-onset of minimally progressive, bilateral, mainly symmetric lower limb spasticity and weakness associated with pes cavus, diminished vibration sense, sphincter disturbances and/or urinary bladder hyperactivity. Additional associated manifestations may include scoliosis, mild intellectual disability, optic atrophy, axonal motor neuropathy and/or distal amyotrophy.

      Statements